The prevalence of thyroid cancer in patients with hyperthyroidism

References

1. ↵
   1. Zhang L,
   2. Li H,
   3. Ji QH,
   4. Zhu YX,
   5. Wang ZY,
   6. Wang Y,
   7. et al.

   (2012) The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease. BMC Cancer 12:610.

   OpenUrlCrossRefPubMed
2. ↵
   1. Yeh NC,
   2. Chou CW,
   3. Weng SF,
   4. Yang CY,
   5. Yen FC,
   6. Lee SY,
   7. et al.

   (2013) Hyperthyroidism and thyroid cancer risk: a population-based cohort study. Exp Clin Endocrinol Diabetes 121:402–406.

   OpenUrlCrossRefPubMed
3. ↵
   1. Cirić J,
   2. Beleslin-Nedeljković B

   (2005) [Differentiated thyroid carcinoma in previously manifested autoimmune thyroid disease]. Srp Arh Celok Lek 133(Suppl 1):74–76, Serbian.

   OpenUrlPubMed
4. ↵
   1. Tamatea JA,
   2. Tu’akoi K,
   3. Conaglen JV,
   4. Elston MS,
   5. Meyer-Rochow GY

   (2014) Thyroid cancer in Graves’ disease: is surgery the best treatment for Graves’ disease? ANZ J Surg 84:231–234.

   OpenUrl
5. ↵
   1. Berker D,
   2. Isik S,
   3. Ozuguz U,
   4. Tutuncu YA,
   5. Kucukler K,
   6. Akbaba G,
   7. et al.

   (2011) Prevalence of incidental thyroid cancer and its ultrasonographic features in subcentimeter thyroid nodules of patients with hyperthyroidism. Endocrine 39:13–20.

   OpenUrlCrossRefPubMed
6. ↵
   1. Belfiore A,
   2. Garofalo MR,
   3. Giuffrida D,
   4. Runello F,
   5. Filetti S,
   6. Fiumara A,
   7. et al.

   (1990) Increased aggressiveness of thyroid cancer in patients with Graves’ disease. J Clin Endocrinol Metab 70:830–835.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Yano Y,
   2. Shibuya H,
   3. Kitagawa W,
   4. Nagahama M,
   5. Sugino K,
   6. Ito K,
   7. et al.

   (2007) Recent outcome of Graves’ disease patients with papillary thyroid cancer. Eur J Endocrinol 157:325–329.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Ahn D,
   2. Sohn JH,
   3. Jeon JH,
   4. Park J

   (2014) Preoperative subclinical hyperthyroidism in patients with papillary thyroid carcinoma. Clin Exp Otorhinolaryngol 7:312–318.

   OpenUrl
9. ↵
   1. Pazaitou-Panayiotou K,
   2. Perros P,
   3. Boudina M,
   4. Siardos G,
   5. Drimonitis A,
   6. Patakiouta F,
   7. et al.

   (2008) Mortality from thyroid cancer in patients with hyperthyroidism: the Theagenion Cancer Hospital experience. Eur J Endocrinol 159:799–803.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Ocak S,
    2. Akten AO,
    3. Tez M

    (2014) Thyroid cancer in hyperthyroid patients: is it different clinical entity? Endocr Regul 48:65–68.

    OpenUrl
11. ↵
    1. Edmonds CJ,
    2. Tellez M

    (1988) Hyperthyroidism and thyroid cancer. Clin Endocrinol (Oxf) 28:253–259.

    OpenUrlPubMed
12. ↵
    1. Sarma SD,
    2. Kumar G,
    3. Kaddour H

    (2014) Thyroid cancer and hyperthyroidism. Otolaryngyl Head & Neck Surg 151:182.

    OpenUrl
13. ↵
    1. Pazaitou-Panayiotou K,
    2. Michalakis K,
    3. Paschke R

    (2012) Thyroid cancer in patients with hyperthyroidism. Horm Metab Res 44:255–262.

    OpenUrlCrossRefPubMed
14. ↵
    1. Hales IB,
    2. McElduff A,
    3. Crummer P,
    4. Clifton-Bligh P,
    5. Delbridge L,
    6. Hoschl R,
    7. et al.

    (2013) Does Graves’ disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab 75:886–889.

    OpenUrl
15. ↵
    1. Kikuchi S,
    2. Noguchi S,
    3. Yamashita H,
    4. Uchino S,
    5. Kawamoto H

    (2006) Prognosis of small thyroid cancer in patients with Graves’ disease. Br J Surg 92:434–439.

    OpenUrl